2022
DOI: 10.1016/j.compositesb.2021.109497
|View full text |Cite
|
Sign up to set email alerts
|

3D printing of multi-functional artificial conduits against acute thrombosis and clinical infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…Many researchers [ 26 , 27 ] have proved that 3D printing of artificial blood vessels is expected to become an effective method for the treatment of cardiovascular and cerebrovascular diseases. However, the current 3D printing technology of artificial blood vessels has not formed a unified and complete process, resulting in the poor controllability of artificial blood vessel molding, which seriously affects the quality of the vascular structure molding [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…Many researchers [ 26 , 27 ] have proved that 3D printing of artificial blood vessels is expected to become an effective method for the treatment of cardiovascular and cerebrovascular diseases. However, the current 3D printing technology of artificial blood vessels has not formed a unified and complete process, resulting in the poor controllability of artificial blood vessel molding, which seriously affects the quality of the vascular structure molding [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…After 7 days, the explanted material indicated significant cell infiltration and lower bacterial infection. 115 Acetylsalicylic acid (ASA) is another antiplatelet agent which was printed together with high (50 000 g/mol) and low (550 g/mol) molecular weight PCL matrices forming small diameter vascular grafts. The grafts showed a reduced platelet adhesion and provided a sustained release of ASA for 2 weeks by diffusion and matrix degradation.…”
Section: Implantable Controlled Release Systemsmentioning
confidence: 99%
“…aureus suspension (10 8 CFU/mL) and subcutaneously implanted in rabbits. After 7 days, the explanted material indicated significant cell infiltration and lower bacterial infection …”
Section: Implantable Controlled Release Systemsmentioning
confidence: 99%